HankeyGJSudlowCLDunbabinDW. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke2000; 31:1779–84.
2.
AmarencoPBogousslavskyJCallahanA3rd. High-dose atorvastatin after stroke after stroke or transient ischemic attack. N Engl J Med2006; 355:549–59.
3.
SaviPZachayusJLDelesque-TouchardN. The active metabolite of clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci U S A2006; 103:11069–74.
4.
JuryECIsenbergDAMauriC. Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus. J Immunol2006; 177:7416–22.
5.
ShimizuMKoharaSYamamotoM. Significant relationship between platelet activation and intra-media thickness of the carotid artery in patients with ischemic cerebrovascular disease. Thromb Res2006; 117:647–52.
6.
HirabayashiHShimizuMKoharaS. Activated platelets in transient global amnesia and TIA. Neurology2004; 63:736–8.
7.
ShimizuMKamioKHaidaM. Platelet activation in patients with obstructive sleep apnea syndrome and effects of nasal-continuous positive airway pressure. Tokai J Exp Clin Med2002; 27:107–12.
8.
IshikawaTShimizuMKoharaS. Appearance of WBC-platelet complex in acute ischemic stroke, predominantly in atherothrombotic infarction. J Atheroscler Thromb2012; 19:494–501.
9.
OffermannsS. Activation of platelet function through G protein-coupled receptors. Circ Res2006; 99:1293–304.
10.
GaetanoGCerlettiCEvangelistaV. Recent advances in platelet polymorphonuclear leukocyte interaction. Haemostasis1999; 29:41–9.
